Comparison of the yield of different screening approaches to detect chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 25, Issue 10, 2010, Pages 3222-3230

  Van Der Velde, Marije ^a   De Jong, Paul E ^a   Gansevoort, Ronald T ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

cardiovascular risk; chronic kidney disease; population screening; renal function loss

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; NETHERLANDS; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; STRUCTURED QUESTIONNAIRE; URINALYSIS;

ADULT; AGED; ALBUMINURIA; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; RENAL INSUFFICIENCY;

EID: 77956249760     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq156     Document Type: Article

References (31)

1. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1-12
2. Hallan SI, Coresh J, Astor BC et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006; 17: 2275-2284
3. Wen CP, Cheng TY, Tsai MK et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008; 371: 2173-2182
4. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266
5. Coresh J, Byrd-Holt D, Astor BC et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 2005; 16: 180-188
6. Ruggenenti P, Perna A, Remuzzi G. ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy. J Am Soc Nephrol 2001; 12: 2832-2837
7. De Jong PE, van der Velde M, Gansevoort RT, Zoccali C. Screening for chronic kidney disease: where does Europe go? Clin J Am Soc Nephrol 2008; 3: 616-623
8. Kallen AJ, Patel PR. In search of a rational approach to chronic kidney disease detection and management. Kidney Int 2007; 72: 3-5
9. El Nahas M. The global challenge of chronic kidney disease. Kidney Int 2005; 68: 2918-2929
10. Hallan SI, Dahl K, Oien CM et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ 2006; 333: 1047
11. De Jong PE, Gansevoort RT. Prevention of chronic kidney disease: the next step forward. Nephrology 2006; 11: 240-244
12. Bang H, Vupputuri S, Shoham DA et al. SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease. Arch Intern Med 2007; 167: 374-381
13. Iseki K. The Okinawa screening program. J Am Soc Nephrol 2003; 14: S127-S130
14. Stevens PE, O'Donoghue DJ, de LS et al. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int 2007; 72: 92-99
15. Lambers Heerspink HJ, Brantsma AH, de Zeeuw D, Bakker SJ, de Jong PE, Gansevoort RT. Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as apredictor of cardiovascular morbidity and mortality. Am J Epidemiol 2008; 168: 897-905
16. Tripepi G, Jager KJ, Dekker FW, Zoccali C. Testing for causality and prognosis: etiological and prognostic models. Kidney Int 2008; 74: 1512-1515
17. Brown WW, Collins A, Chen SC et al. Identification of persons at high risk for kidney disease via targeted screening: the NKF Kidney Early Evaluation Program. Kidney Int Suppl 2003;S50-S55
18. Krol E, Rutkowski B, Czarniak P et al. Early detection of chronic kidney disease: results of the PolNef Study. Am J Nephrol 2008; 29: 264-273
19. Eckardt KU, Berns JS, Rocco MV, Kasiske BL. Definition and classification of CKD: the debate should be about patient prognosis\a position statement from KDOQI and KDIGO. Am J Kidney Dis 2009; 53: 915-920
20. Clase CM. Glomerular filtration rate: screening cannot be recommended on the basis of current knowledge. BMJ 2006; 333: 1030-1031
21. National Screening Committee. The National Screening Committee Handbook of Population Screening Programmes. Health Departments of the United Kingdom, 1998. http://www.dh.gov.uk/en/Publications andstatistics/Publications/ PublicationsPolicyAndGuidance/DH-4006774
22. World Health Organization. Mass Health Examinations. Geneva: WHO, 1971
23. Andermann A, Blancquaert I, Beauchamp S, Dery V. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ 2008; 86: 317-319
24. Wilson JMG, Jungner G. Principles and Practice of Screening for Disease. Geneva: WHO, 1968
25. Adamczak M, Zeier M, Dikow R, Ritz E. Kidney and hypertension. Kidney Int Suppl 2002; 62-67
26. Atthobari J, Asselbergs FW, Boersma C et al. Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: a pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT). Clin Ther 2006; 28: 432-444
27. Boersma C, Voors AA, Visser ST, de Jong-van den Berg LT, Postma MJ. Cost effectiveness of angiotensin receptor blocker monotherapy in patients with hypertension in the Netherlands: a comparative analysis using clinical trial and drug utilization data. Am J Cardiovasc Drugs 2010; 10: 49-54
28. Brantsma AH, Bakker SJ, de Zeeuw D, de Jong PE, Gansevoort RT. Extended prognostic value of urinary albumin excretion for cardiovascular events. J Am Soc Nephrol 2008; 19: 1785-1791
29. Baan C, Bonneux L, Ruwaard D, Feskens EJM. The prevalence of diabetes mellitus in the Netherlands. Eur J Public Health 1998; 8: 210-216
30. Imai E, Horio M, Yamagata K et al. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. Hypertens Res 2008; 31: 433-441
31. Levey AS, Greene T, Kusek JW, Beck GJ. Simplified equation to predict glomerular filtration rate from serum creatinine [abstract]. J Am Soc Nephrol 2000; 11: 155A